Department of Veterinary Physiology and Pharmacology, Texas A&M University, College Station, TX, USA.
Department of Veterinary Physiology and Pharmacology, Texas A&M University, College Station, TX, USA.
Regul Toxicol Pharmacol. 2022 Jul;132:105197. doi: 10.1016/j.yrtph.2022.105197. Epub 2022 May 28.
Addressing inter- and intra-species differences in potential hazardous effects of chemicals remains a long-standing challenge in human health risk assessment that is typically addressed heuristically through use of 10-fold default "uncertainty" or "safety" factors. Although it has long been recognized that chemical-specific data would be preferable to replace the "defaults," only recently have there emerged experimental model systems and organisms with the potential to experimentally quantify the population variability in both toxicokinetics and toxicodynamics for specific chemicals. Progress is most evident in the use of population in vitro human cell-based models and population in vivo mouse models. Multiple case studies were published in the past 10-15 years that clearly demonstrate the utility of such models to derive data with direct application to quantifying variability at hazard identification, exposure-response assessment, and mechanistic understanding of toxicity steps of traditional risk assessments. Here, we review recent efforts to develop fit-for-purpose approaches utilizing these novel population-based in vitro and in vivo models in the context of risk assessment. We also describe key challenges and opportunities to broadening application of population-based experimental approaches. We conclude that population-based models are now beginning to realize their potential to address long-standing data gaps in inter- and intra-species variability.
解决化学物质潜在危害效应的种间和种内差异仍然是人类健康风险评估中的一个长期存在的挑战,通常通过使用 10 倍默认的“不确定性”或“安全性”因素来进行启发式处理。尽管人们早就认识到,最好使用特定于化学物质的数据来替代“默认值”,但直到最近才出现了具有实验潜力的模型系统和生物体,可以在毒代动力学和毒效动力学方面对特定化学物质的种群变异性进行实验量化。在使用人群体外基于细胞的模型和人群体内小鼠模型方面取得了最大的进展。在过去的 10-15 年中,发表了多个案例研究,清楚地表明了这些模型在危害识别、暴露-反应评估以及传统风险评估毒性步骤的机制理解中,利用这些模型获取数据来量化变异性的实用性。在这里,我们回顾了最近利用这些新的基于人群的体外和体内模型在风险评估背景下开发适合用途方法的努力。我们还描述了拓宽基于人群的实验方法应用的关键挑战和机遇。我们得出结论,基于人群的模型现在开始意识到它们有潜力解决种间和种内变异性中长期存在的数据差距。